Sun Pharma Acquires Organon in $11.75 Billion Deal – India’s Biggest Overseas Pharma Buy
Sun Pharma will buy Organon for $11.75B, boosting global reach, women’s health, and specialty drugs, and creating a $12.4B annual revenue pharma giant.
Sun Pharma will buy Organon for $11.75B, boosting global reach, women’s health, and specialty drugs, and creating a $12.4B annual revenue pharma giant.
Sun Pharma offers $13B to buy Organon, aiming to expand globally in branded drugs, competing with EQT and Grünenthal.
Sun Pharma fell 4% after a $12B bid for Organon, raising debt worries despite strong cash and ongoing deal talks.
Organon's (OGN) CEO Kevin Ali resigns following internal probe into Nexplanon birth-control implant sales practices. Company appoints interim chief and implements corrective measures.